Related Experiment Video

Updated: Jun 4, 2025

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
09:13

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases

Published on: November 22, 2024

1.3K

Substrate and inhibitor specificity of Plasmodium nucleoside transporters ENT1 orthologs

Xinyi Chen1, Chengyu Tian2, Yingying He1

  • 1Department of Obstetrics, Key Laboratory of Birth Defects and Related Disease of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University, Chengdu, China.

The Journal of Biological Chemistry
|December 26, 2024
PubMed

Insights

Researchers compared Plasmodium nucleoside transporters, finding distinct selectivities and varying inhibitor binding. This research advances antimalarial drug development by optimizing inhibitors for Plasmodium falciparum equilibrative nucleoside transporter 1 (PfENT1).

Area of Science:

  • Malariology
  • Parasitology
  • Drug Discovery

Background:

  • Malaria remains a significant global health threat, caused by Plasmodium parasites.
  • Plasmodium falciparum equilibrative nucleoside transporter 1 (PfENT1) is crucial for parasite growth and a potential antimalarial drug target.
  • The inhibitor GSK4 shows promise in targeting PfENT1, but its efficacy across different Plasmodium species needs investigation.

Purpose of the Study:

  • To compare the nucleoside selectivity of Plasmodium ENT1 orthologs from different species.
  • To assess the binding affinity of GSK4 and its analogs to Plasmodium ENT1 orthologs.
  • To explore structural optimization of GSK4 for enhanced antimalarial drug development.

Main Methods:

  • Systematic comparison of nucleoside selectivity across Plasmodium falciparum (PfENT1), Plasmodium berghei (PbENT1), and Plasmodium vivax (PvENT1) orthologs.
  • Evaluation of GSK4 binding affinity to different Plasmodium ENT1 orthologs.
  • Structural optimization of GSK4 and generation of novel analogs.

Main Results:

  • Plasmodium ENT1 orthologs exhibit distinct nucleoside recognition patterns.
  • GSK4 demonstrates strong binding to PfENT1 and PvENT1 but weaker binding to PbENT1.
  • One GSK4 analog showed a slightly increased binding affinity for PfENT1.

Conclusions:

  • Plasmodium ENT1 orthologs have species-specific differences in nucleoside and inhibitor recognition.
  • GSK4's efficacy varies across Plasmodium species, highlighting the need for targeted drug design.
  • Optimized GSK4 analogs offer a promising foundation for developing new antimalarial therapies.

More Related Videos

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum10:22

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum

Published on: December 4, 2015

8.8K
Development of a Negative Selectable Marker for Entamoeba histolytica06:05

Development of a Negative Selectable Marker for Entamoeba histolytica

Published on: December 12, 2010

12.4K

Related Concept Videos

ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
4.1K
The Significance of Membrane Transport01:44

The Significance of Membrane Transport

The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
23.0K
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.1K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
254
Facilitated Diffusion01:16

Facilitated Diffusion

The plasma membrane, a critical structure in cellular biology, houses an array of transporters, or carrier proteins, interspersed within its lipid bilayer. These proteins play a crucial role in solute transport through facilitated diffusion, a form of passive diffusion that uses transporters to move the molecules across the membrane.
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...
293
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
77.9K